Cargando…
Association Between Peripheral Adiponectin and Lipids Levels and the Therapeutic Response to Donepezil Treatment in Han Chinese Patients With Alzheimer’s Disease
Acetylcholinesterase inhibitors (AChEIs) including donepezil (DNP) are considered to be the most promising therapeutic possibilities of Alzheimer’s disease (AD). The response to DNP in AD patients varies and it is valuable to identify the potential markers that can predict the efficacy. Moreover, DN...
Autores principales: | Wan, Lili, Lu, Jin, Huang, Jinlu, Huo, Yan, Jiang, Shan, Guo, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518373/ https://www.ncbi.nlm.nih.gov/pubmed/33061904 http://dx.doi.org/10.3389/fnagi.2020.532386 |
Ejemplares similares
-
Commentary: Donepezil enhances understanding of degraded speech in Alzheimer's disease
por: Campbell, Tom A., et al.
Publicado: (2018) -
Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022) -
Blood-Derived Plasma Protein Biomarkers for Alzheimer’s Disease in Han Chinese
por: Cheng, Zaohuo, et al.
Publicado: (2018) -
Cofilin 2 in Serum as a Novel Biomarker for Alzheimer’s Disease in Han Chinese
por: Sun, Yingni, et al.
Publicado: (2019) -
Efficacy of THN201, a Combination of Donepezil and Mefloquine, to Reverse Neurocognitive Deficits in Alzheimer’s Disease
por: Droguerre, Marine, et al.
Publicado: (2020)